Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson’s disease

Table 3 Preliminary efficacy

	Baseline (Mean ± SD)	Follow-Up (Mean ± SD)	Cohen’s d	p - value	n
Visual Learning – BVMT-R	16.3 ± 6.6	20.3 ± 5.8	0.64	0.50	13
Reaction Time – Cogstate	2.55 ± 0.04	2.53 ± 0.06	− 0.46	0.19	8
Choice Reaction Time – Cogstate	2.75 ± 0.06	2.72 ± 0.07	−0.38	0.08	7
Negative Affect - PANAS	16.4 ± 5.0	13.8 ± 3.5	−0.59	0.01*	11
Positive Affect - PANAS	36.4 ± 7.3	34.3 ± 7.5	−0.19	0.24	12
PROMIS Fatigue	18.6 ± 3.5	16.9 ± 3.8	−0.45	0.10	12
PROMIS Sleep	31.4 ± 5.3	29.1 ± 6.3	−0.40	0.16	12

*Statistical significance at p > 0.05 level. Not all participants had the capacity to complete all assessments due to motor impairment
Brief Visuospatial Memory Test Revised (BVMT-R) [32]
Cogstate Brief Battery [33]
Positive and Negative Affect Schedule (PANAS) [36]
Patient Reported Outcomes Measurement Information System (PROMIS) [35]

ISSN: 1743-0003